About Penta
Who we are
Our Strategy
Our Network
Working Groups
Penta Foundation
Our Staff
Diversity and Inclusion
Annual reports
Our Activities
News & Webinars
News
Press center
Penta Newsletter
Stories
Scientific Views
Penta Aperitivo Webinars
Publications
Contact us
Work with us
Vacancies
Calls for service
PentaTr@ining
Archivio
Current evidence for the use of pediatric antiretroviral therapy – a PENTA analysis
Variable use of therpaeutic interventions for children with human immunodeficiency virus type 1 infection in Europe.
Reconstitution of the T-cell Pool in Treated, HIV-infected Children
Immune repopulation after HAART in previously untreated HIV-1 infected children
A randomised trial evaluating three NRTI regimens with and without Nelfinavir in HIV-infected children: 48 week follow-up from the PENTA 5 trial
Drug resistance in a trial of nucleoside analogue and protease inhibitor therapy in children (PENTA 5)